APA (7th ed.) Citation

Naranjo, A., Hackett, G. I., Smith, S., Stephens, H., Kinnaird, W., & Kirby, M. (2026). Evidence for the Additional Health Benefits Associated with Phosphodiesterase 5 Inhibitors when Used for Treating Erectile Dysfunction, with a Focus on Prostate Cancer Patients and Other Associated Conditions. World Journal of Men's Health, 44(3), 582. https://doi.org/10.5534/wjmh.250313

Chicago Style (17th ed.) Citation

Naranjo, Alexandra, Geoffrey Ian Hackett, Sophie Smith, Harley Stephens, William Kinnaird, and Mike Kirby. "Evidence for the Additional Health Benefits Associated with Phosphodiesterase 5 Inhibitors When Used for Treating Erectile Dysfunction, with a Focus on Prostate Cancer Patients and Other Associated Conditions." World Journal of Men's Health 44, no. 3 (2026): 582. https://doi.org/10.5534/wjmh.250313.

MLA (9th ed.) Citation

Naranjo, Alexandra, et al. "Evidence for the Additional Health Benefits Associated with Phosphodiesterase 5 Inhibitors When Used for Treating Erectile Dysfunction, with a Focus on Prostate Cancer Patients and Other Associated Conditions." World Journal of Men's Health, vol. 44, no. 3, 2026, p. 582, https://doi.org/10.5534/wjmh.250313.